Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• (untitled)8 passages
• 9p21.3 Coronary Artery Disease Locus Identifies Patients With Treatment Benefit From Bariatric Surgery in the Nonrandomized Prospective Controlled Swedish Obese Subjects Study.1 passage
• A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.1 passage
• A Screening Approach to Identify Clinically Actionable Variants Causing Congenital Heart Disease in Exome Data.1 passage
• A-Band Titin Truncation in Zebrafish Causes Dilated Cardiomyopathy and Hemodynamic Stress Intolerance.1 passage
• Ability of Patients to Distinguish Among Cardiac Genomic Variant Subclassifications.1 passage
• Accuracy of Clinical Diagnostic Criteria for Patients With Vascular Ehlers-Danlos Syndrome in a Tertiary Referral Centre.1 passage
• Accuracy of Clinical Diagnostic Criteria for Patients with Vascular Ehlers-Danlos Syndrome in a Tertiary Referral Centre.1 passage
• Alcohol Consumption and Cardiovascular Disease: A Mendelian Randomization Study.1 passage
• Amino Acid-Level Signal-to-Noise Analysis Aids in Pathogenicity Prediction of Incidentally Identified1 passage
• Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo.1 passage
• Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance.1 passage
• Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.1 passage
• Association of Genetic Instrumental Variables for Lung Function on Coronary Artery Disease Risk: A 2-Sample Mendelian Randomization Study.1 passage
• Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women.1 passage
• Associations Between Alcohol Intake and Genetic Predisposition With Atrial Fibrillation Risk in a National Biobank.1 passage
• Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.1 passage
• Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry.1 passage
• Bayesian Inference Associates Rare1 passage
• Biallelic Variants in1 passage
• Biomarker Glycoprotein Acetyls Is Associated With the Risk of a Wide Spectrum of Incident Diseases and Stratifies Mortality Risk in Angiography Patients.1 passage
• Birthweight, Type 2 Diabetes Mellitus, and Cardiovascular Disease: Addressing the Barker Hypothesis With Mendelian Randomization.1 passage
• Bivariate Genome-Wide Association Scan Identifies 6 Novel Loci Associated With Lipid Levels and Coronary Artery Disease.1 passage
• Blood Pressure-Associated Genetic Variants in the Natriuretic Peptide Receptor 1 Gene Modulate Guanylate Cyclase Activity.1 passage
• Burden of Cardiomyopathic Genetic Variation in Lethal Pediatric Myocarditis.1 passage
• CETP (Cholesteryl Ester Transfer Protein) Concentration: A Genome-Wide Association Study Followed by Mendelian Randomization on Coronary Artery Disease.1 passage
• Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features.1 passage
• Cardiac Dysfunction in Duchenne Muscular Dystrophy Is Less Frequent in Patients With Mutations in the Dystrophin Dp116 Coding Region Than in Other Regions.1 passage
• Cardiac Imaging of Aortic Valve Area From 34 287 UK Biobank Participants Reveals Novel Genetic Associations and Shared Genetic Comorbidity With Multiple Disease Phenotypes.1 passage
• Cardiac α-Actin (ACTC1) Gene Mutation Causes Atrial-Septal Defects Associated With Late-Onset Dilated Cardiomyopathy.1 passage
• Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association.1 passage
• Categorized Genetic Analysis in Childhood-Onset Cardiomyopathy.1 passage
• Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort.1 passage
• Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.1 passage
• Chemotherapy-Related Cardiac Dysfunction: A Systematic Review of Genetic Variants Modulating Individual Risk.1 passage
• Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women.1 passage
• Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease.1 passage
• Clinical Conditions and Their Impact on Utility of Genetic Scores for Prediction of Acute Coronary Syndrome.1 passage
• Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants.1 passage
• Clinical Genetic Risk Variants Inform a Functional Protein Interaction Network for Tetralogy of Fallot.1 passage
• Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection.1 passage
• Clinical Outcomes and Sustainability of Using1 passage
• Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry.1 passage
• Clinical Utility of a Phenotype-Enhanced1 passage
• Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis.1 passage
• Coagulation Factors and the Risk of Ischemic Heart Disease: A Mendelian Randomization Study.1 passage
• Combining Clinical and Polygenic Risk Improves Stroke Prediction Among Individuals With Atrial Fibrillation.1 passage
• Common Coding Variants in1 passage
• Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval.1 passage
• Comprehensive Investigation of Circulating Biomarkers and Their Causal Role in Atherosclerosis-Related Risk Factors and Clinical Events.1 passage
• Confirmation of Causal rs9349379- PHACTR1 Expression Quantitative Trait Locus in Human-Induced Pluripotent Stem Cell Endothelial Cells.1 passage
• Conserved Role of the Large Conductance Calcium-Activated Potassium Channel, K1 passage
• Considerations for Cardiovascular Genetic and Genomic Research With Marginalized Racial and Ethnic Groups and Indigenous Peoples: A Scientific Statement From the American Heart Association.1 passage
• Contribution of Noncanonical Splice Variants to1 passage
• Corrected QT Interval-Polygenic Risk Score and Its Contribution to Type 1, Type 2, and Type 3 Long-QT Syndrome in Probands and Genotype-Positive Family Members.1 passage
• Correction to: Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition: A Genome-Wide Association Study and Mendelian Randomization Study in the HUNT, Norway.1 passage
• Dawn of Epitranscriptomic Medicine.1 passage
• De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart Disease.1 passage
• Deep Mutational Scan of an1 passage
• Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.1 passage
• Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome.1 passage
• Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes.1 passage
• Druggability of Coronary Artery Disease Risk Loci.1 passage
• Effect of Ascertainment Bias on Estimates of Patient Mortality in Inherited Cardiac Diseases.1 passage
• Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings.1 passage
• Effects of Genetic Variants Associated with Familial Hypercholesterolemia on Low-Density Lipoprotein-Cholesterol Levels and Cardiovascular Outcomes in the Million Veteran Program.1 passage
• Epigenetic Analyses of Human Left Atrial Tissue Identifies Gene Networks Underlying Atrial Fibrillation.1 passage
• Epigenome-Wide Association Study Identifies a Novel DNA Methylation in Patients With Severe Aortic Valve Stenosis.1 passage
• Epigenomic Profiles of African-American1 passage
• Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association.1 passage
• Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare1 passage
• Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.1 passage
• Evaluation of Clinical Practices Related to Variants of Uncertain Significance Results in Inherited Cardiac Arrhythmia and Inherited Cardiomyopathy Genes.1 passage
• Exome Sequencing and Congenital Heart Disease in Sub-Saharan Africa.1 passage
• Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults.1 passage
• ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals.1 passage
• FADS1 (Fatty Acid Desaturase 1) Genotype Associates With Aortic Valve FADS mRNA Expression, Fatty Acid Content and Calcification.1 passage
• Familial Sinus Node Disease Caused by a Gain of GIRK (G-Protein Activated Inwardly Rectifying K1 passage
• Founder Mutation in N Terminus of Cardiac Troponin I Causes Malignant Hypertrophic Cardiomyopathy.1 passage
• From Genotype to Phenotype: A Primer on the Functional Follow-up of Genome-Wide Association Studies in Cardiovascular Disease.1 passage
• Functional Assays to Screen and Dissect Genomic Hits: Doubling Down on the National Investment in Genomic Research.1 passage
• Functionally Conserved Noncoding Regulators of Cardiomyocyte Proliferation and Regeneration in Mouse and Human.1 passage
• Genetic Analysis of Patients With Sickle Cell Anemia and Stroke Before 4 Years of Age Suggest an Important Role for Apoliprotein E.1 passage
• Genetic Assessment of Potential Long-Term On-Target Side Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors.1 passage
• Genetic Association Analyses Highlight1 passage
• Genetic Association Between Hypoplastic Left Heart Syndrome and Cardiomyopathies.1 passage
• Genetic Basis and Prognostic Value of Exercise QT Dynamics.1 passage
• Genetic Control of Left Atrial Gene Expression Yields Insights into the Genetic Susceptibility for Atrial Fibrillation.1 passage
• Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation.1 passage
• Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation.1 passage
• Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy.1 passage
• Genetic Mosaicism in Calmodulinopathy.1 passage
• Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus.1 passage
• Genetic Reduction in Left Ventricular Protein Kinase C-α and Adverse Ventricular Remodeling in Human Subjects.1 passage
• Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels and Its Impact on Atherosclerotic Vascular Disease Phenotypes.1 passage
• Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease.1 passage
• Genetic Risk Scores for Complex Disease Traits in Youth.1 passage
• Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in1 passage
• Genetic Susceptibility Loci for Cardiovascular Disease and Their Impact on Atherosclerotic Plaques.1 passage
• Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics: Yield and Clinical Significance.1 passage
• Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients: A Scientific Statement From the American Heart Association.1 passage
• Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association.1 passage
• Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).1 passage
• Genetically Determined Birthweight Associates With Atrial Fibrillation: A Mendelian Randomization Study.1 passage
• Genetically Determined Serum Calcium Levels and Markers of Ventricular Repolarization: A Mendelian Randomization Study in the UK Biobank.1 passage
• Genetics of Circulating Resistin Level, a Biomarker for Cardiovascular Diseases, Is Informed by Mendelian Randomization and the Unique Characteristics of African Genomes.1 passage
• Genome-Wide Association Meta-Analysis Supports Genes Involved in Valve and Cardiac Development to Associate With Mitral Valve Prolapse.1 passage
• Genome-Wide Association Study of Peripheral Artery Disease.1 passage
• Genome-Wide Association Study of the Postprandial Triglyceride Response Yields Common Genetic Variation in LIPC (Hepatic Lipase).1 passage
• Genome-Wide Association Study-Driven Gene-Set Analyses, Genetic, and Functional Follow-Up Suggest GLIS1 as a Susceptibility Gene for Mitral Valve Prolapse.1 passage
• Genome-Wide Association of Kidney Traits in Hispanics/Latinos Using Dense Imputed Whole-Genome Sequencing Data: The Hispanic Community Health Study/Study of Latinos.1 passage
• Genome-Wide Polygenic Score and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study.1 passage
• Genomic Risk Stratification Predicts All-Cause Mortality After Cardiac Catheterization.1 passage
• Genotype-Based Recall Studies in Complex Cardiometabolic Traits.1 passage
• Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.1 passage
• Genotype-Guided P2Y1 passage
• Genotype-Phenotype Correlation of1 passage
• Gut Microbiome and Response to Cardiovascular Drugs.1 passage
• Healthcare Utilization and Patients' Perspectives After Receiving a Positive Genetic Test for Familial Hypercholesterolemia.1 passage
• Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association.1 passage
• Heterogeneity of the Predictive Polygenic Risk Scores for Coronary Heart Disease Age-at-Onset in Three Different Coronary Heart Disease Family-Based Ascertainments.1 passage
• Heterozygous1 passage
• High-Resolution Regulatory Maps Connect Vascular Risk Variants to Disease-Related Pathways.1 passage
• High-Throughput Functional Evaluation of KCNQ1 Decrypts Variants of Unknown Significance.1 passage
• Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future.1 passage
• Human Urinary mRNA as a Biomarker of Cardiovascular Disease.1 passage
• Hyperacute Monocyte Gene Response Patterns Are Associated With Lower Extremity Vein Bypass Graft Failure.1 passage
• Identification of Circulating Proteins Associated With Blood Pressure Using Mendelian Randomization.1 passage
• Identification of Common and Rare Genetic Variation Associated With Plasma Protein Levels Using Whole-Exome Sequencing and Mass Spectrometry.1 passage
• Identification of Functional Genetic Determinants of Cardiac Troponin T and I in a Multiethnic Population and Causal Associations With Atrial Fibrillation.1 passage
• Identifying the Lipidomic Effects of a Rare Loss-of-Function Deletion in1 passage
• Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.1 passage
• Impact of Genetic Testing for Cardiomyopathy on Emotional Well-Being and Family Dynamics: A Study of Parents and Adolescents.1 passage
• Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria.1 passage
• Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association.1 passage
• Impact of Pathogenic1 passage
• Implications of Genetic Testing in Dilated Cardiomyopathy.1 passage
• Improving Interpretation of Cardiac Phenotypes and Enhancing Discovery With Expanded Knowledge in the Gene Ontology.1 passage
• Increased Burden of Ion Channel Gene Variants Is Related to Distinct Phenotypes in Pediatric Patients With Left Ventricular Noncompaction.1 passage
• Increased Prevalence of Congenital Heart Disease in Children With Diamond Blackfan Anemia Suggests Unrecognized Diamond Blackfan Anemia as a Cause of Congenital Heart Disease in the General Population: A Report of the Diamond Blackfan Anemia Registry.1 passage
• Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.1 passage
• Integrated Multiomics Approach to Identify Genetic Underpinnings of Heart Failure and Its Echocardiographic Precursors: Framingham Heart Study.1 passage
• Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction.1 passage
• Integration of Large-Scale Genomic Data Sources With Evolutionary History Reveals Novel Genetic Loci for Congenital Heart Disease.1 passage
• Integrative Functional Annotation of 52 Genetic Loci Influencing Myocardial Mass Identifies Candidate Regulatory Variants and Target Genes.1 passage
• Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels.1 passage
• Interactions Between Regulatory Variants in CYP7A1 (Cholesterol 7α-Hydroxylase) Promoter and Enhancer Regions Regulate CYP7A1 Expression.1 passage
• Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association.1 passage
• Interleukin-6 Receptor Signaling and Abdominal Aortic Aneurysm Growth Rates.1 passage
• International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework.1 passage
• International Triadin Knockout Syndrome Registry.1 passage
• Interpretation of Incidental Genetic Findings Localizing to Genes Associated With Cardiac Channelopathies and Cardiomyopathies.1 passage
• Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy.1 passage
• Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy.1 passage
• LITAF (Lipopolysaccharide-Induced Tumor Necrosis Factor) Regulates Cardiac L-Type Calcium Channels by Modulating NEDD (Neural Precursor Cell Expressed Developmentally Downregulated Protein) 4-1 Ubiquitin Ligase.1 passage
• Large-Scale Phenome-Wide Association Study of1 passage
• Letter by Aw et al Regarding Article, "Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention".1 passage
• Letter by Groth et al Regarding Article, "Impact of Pathogenic FBN1 (Fibrillin-1) Variant Types on the Progression of Aortic Disease in Patients With Marfan Syndrome".1 passage
• Life-Time Covariation of Major Cardiovascular Diseases: A 40-Year Longitudinal Study and Genetic Studies.1 passage
• Lifelong Reduction in LDL (Low-Density Lipoprotein) Cholesterol due to a Gain-of-Function Mutation in1 passage
• Lipidomics, Atrial Conduction, and Body Mass Index.1 passage
• Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions.1 passage
• Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.1 passage
• Meta-Analysis of 26 638 Individuals Identifies Two Genetic Loci Associated With Left Ventricular Ejection Fraction.1 passage
• Metabolic Age Based on the BBMRI-NL1 passage
• Metabolic Dysregulation of the Lysophospholipid/Autotaxin Axis in the Chromosome 9p21 Gene SNP rs10757274.1 passage
• Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women.1 passage
• Mono- and Biallelic Protein-Truncating Variants in Alpha-Actinin 2 Cause Cardiomyopathy Through Distinct Mechanisms.1 passage
• Monoallelic Mutations in1 passage
• Moving Genomics to Routine Care: An Initial Pilot in Acute Cardiovascular Disease.1 passage
• Multi-Ethnic Genome-Wide Association Study of Decomposed Cardioelectric Phenotypes Illustrates Strategies to Identify and Characterize Evidence of Shared Genetic Effects for Complex Traits.1 passage
• Multiethnic Genome-Wide Association Study of Subclinical Atherosclerosis in Individuals With Type 2 Diabetes.1 passage
• Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Nonsegregating LMNA Pedigrees.1 passage
• Multiomic Profiling in Black and White Populations Reveals Novel Candidate Pathways in Left Ventricular Hypertrophy and Incident Heart Failure Specific to Black Adults.1 passage
• Multiomics Screening Identifies Molecular Biomarkers Causally Associated With the Risk of Coronary Artery Disease.1 passage
• Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of High-Density Lipoprotein Cholesterol in Humans.1 passage
• New Case Detection by Cascade Testing in Familial Hypercholesterolemia: A Systematic Review of the Literature.1 passage
• Nocturnal Atrial Fibrillation Caused by Mutation in KCND2, Encoding Pore-Forming (α) Subunit of the Cardiac Kv4.2 Potassium Channel.1 passage
• Noncoding Genetic Variation and Gene Expression: Deciphering the Molecular Drivers of Genome-Wide Association Study Signals in Atrial Fibrillation.1 passage
• Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association.1 passage
• Novel Biomarkers for the Precisive Diagnosis and Activity Classification of Takayasu Arteritis.1 passage
• Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.1 passage
• Partitioning the Pleiotropy Between Coronary Artery Disease and Body Mass Index Reveals the Importance of Low Frequency Variants and Central Nervous System-Specific Functional Elements.1 passage
• Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis.1 passage
• Patients With Hypertrophic Cardiomyopathy Deemed Genotype Negative Based on Research Grade Genetic Analysis: Time for Repeat Diagnostic Testing With Next-Generation Sequencing.1 passage
• Peripheral Blood RNA Levels of1 passage
• Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT.1 passage
• Physical Activity, Sedentary Leisure Time, Circulating Metabolic Markers, and Risk of Major Vascular Diseases.1 passage
• Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction.1 passage
• Polygenic Contribution in Individuals With Early-Onset Coronary Artery Disease.1 passage
• Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.1 passage
• Polygenic Hyperlipidemias and Coronary Artery Disease Risk.1 passage
• Polygenic Risk Score for Coronary Artery Disease Improves the Prediction of Early-Onset Myocardial Infarction and Mortality in Men.1 passage
• Polygenic Risk Score for Coronary Heart Disease Modifies the Elevated Risk by Cigarette Smoking for Disease Incidence.1 passage
• Polygenic Risk Score for Low-Density Lipoprotein Cholesterol Is Associated With Risk of Ischemic Heart Disease and Enriches for Individuals With Familial Hypercholesterolemia.1 passage
• Polygenic Risk Score to Identify Subclinical Coronary Heart Disease Risk in Young Adults.1 passage
• Polygenic Risk Score-Enhanced Risk Stratification of Coronary Artery Disease in Patients With Stable Chest Pain.1 passage
• Population Bias in Polygenic Risk Prediction Models for Coronary Artery Disease.1 passage
• Portfolio Analysis of Research Grants in Data Science Funded by the National Heart, Lung, and Blood Institute.1 passage
• Postmortem Genetic Testing for Cardiac Ion Channelopathies in Stillbirths.1 passage
• Prediction of Genotype Positivity in Patients With Hypertrophic Cardiomyopathy Using Machine Learning.1 passage
• Predictive Accuracy of a Clinical and Genetic Risk Model for Atrial Fibrillation.1 passage
• Predictive Accuracy of a Polygenic Risk Score for Postoperative Atrial Fibrillation After Cardiac Surgery.1 passage
• Preferences for Return of Genetic Results Among Participants in the Jackson Heart Study and Framingham Heart Study.1 passage
• Prevalence and Electronic Health Record-Based Phenotype of Loss-of-Function Genetic Variants in Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Genes.1 passage
• Prevalence and Outcomes of p.Val142Ile1 passage
• Promise and Peril of Population Genomics for the Development of Genome-First Approaches in Mendelian Cardiovascular Disease.1 passage
• Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.1 passage
• Prospective1 passage
• Prospective Cardiovascular Genetics Evaluation in Spontaneous Coronary Artery Dissection.1 passage
• Prospective Study of Epigenetic Age Acceleration and Incidence of Cardiovascular Disease Outcomes in the ARIC Study (Atherosclerosis Risk in Communities).1 passage
• Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.1 passage
• Randomization of Left-right Asymmetry and Congenital Heart Defects: The Role of1 passage
• Rare Coding Variants Associated With Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-Ancestry Analysis.1 passage
• Rare Missense Variants in TLN1 Are Associated With Familial and Sporadic Spontaneous Coronary Artery Dissection.1 passage
• Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease.1 passage
• Rare, Damaging DNA Variants in1 passage
• Recent Advances on the Genetics of Spontaneous Coronary Artery Dissection.1 passage
• Reevaluation of the South Asian1 passage
• Response by Ingles and Semsarian to Letter Regarding Article, "Concealed Arrhythmogenic Right Ventricular Cardiomyopathy in Sudden Unexplained Cardiac Death Events".1 passage
• Response by Takeda et al to Letter Regarding Article, "Impact of Pathogenic FBN1 Variant Types on the Progression of Aortic Disease in Patients With Marfan Syndrome".1 passage
• Rho Guanine Nucleotide Exchange Factor1 passage
• Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.1 passage
• Role of Rare and Low-Frequency Variants in Gene-Alcohol Interactions on Plasma Lipid Levels.1 passage
• Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic1 passage
• Sexual Differences in Genetic Predisposition of Coronary Artery Disease.1 passage
• Single-Nucleotide Polymorphism of the MLX Gene Is Associated With Takayasu Arteritis.1 passage
• Smoking is Associated to DNA Methylation in Atherosclerotic Carotid Lesions.1 passage
• Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Blacks.1 passage
• Spatial and Functional Distribution of1 passage
• Spontaneous Coronary Artery Dissection: Insights on Rare Genetic Variation From Genome Sequencing.1 passage
• Subsequent Event Risk in Individuals With Established Coronary Heart Disease.1 passage
• Subtype Specificity of Genetic Loci Associated With Stroke in 16 664 Cases and 32 792 Controls.1 passage
• Sugar-Sweetened Beverage Consumption May Modify Associations Between Genetic Variants in the CHREBP (Carbohydrate Responsive Element Binding Protein) Locus and HDL-C (High-Density Lipoprotein Cholesterol) and Triglyceride Concentrations.1 passage
• System Genetics Including Causal Inference Identify Immune Targets for Coronary Artery Disease and the Lifespan.1 passage
• Systematic Evaluation of1 passage
• Systems Pharmacology Identifies an Arterial Wall Regulatory Gene Network Mediating Coronary Artery Disease Side Effects of Antiretroviral Therapy.1 passage
• Tailoring the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Guidelines for the Interpretation of Sequenced Variants in the1 passage
• The Propagation of Racial Disparities in Cardiovascular Genomics Research.1 passage
• Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.1 passage
• Tissue-Specific Differential Expression of Novel Genes and Long Intergenic Noncoding RNAs in Humans With Extreme Response to Evoked Endotoxemia.1 passage
• Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in1 passage
• Transethnic Meta-Analysis of Genome-Wide Association Studies Identifies Three New Loci and Characterizes Population-Specific Differences for Coronary Artery Disease.1 passage
• Triadin Knockout Syndrome Is Absent in a Multi-Center Molecular Autopsy Cohort of Sudden Infant Death Syndrome and Sudden Unexplained Death in the Young and Is Extremely Rare in the General Population.1 passage
• Truncating Variants in1 passage
• Use of a Polygenic Risk Score Improves Prediction of Myocardial Injury After Non-Cardiac Surgery.1 passage
• Using Statistical Modeling to Understand and Predict Pediatric Stem Cell Function.1 passage
• Utility of Genetically Predicted Lp(a) (Lipoprotein [a]) and ApoB Levels for Cardiovascular Risk Assessment.1 passage
• Validation and Disease Risk Assessment of Previously Reported Genome-Wide Genetic Variants Associated With Brugada Syndrome: SADS-TW BrS Registry.1 passage
• Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.1 passage
• Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.1 passage
• Variant Reinterpretation in Survivors of Cardiac Arrest With Preserved Ejection Fraction (the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) by Clinicians and Clinical Commercial Laboratories.1 passage
• Variants in NKX2-5 and FLNC Cause Dilated Cardiomyopathy and Sudden Cardiac Death.1 passage
• Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition.1 passage
• Whole Blood DNA Methylation Signatures of Diet Are Associated With Cardiovascular Disease Risk Factors and All-Cause Mortality.1 passage
• Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy.1 passage
• Yield of the1 passage